Filomena Trindade, MD, MPH,MS- A Personalized Approach to the Complex Patient (continued)
Thursday, April 26- Women an cognition: Insulin, menopause and Alzheimer’s
Sat, Mar 31, 2018 6:00 PM - 7:30 PM AEDT
Toxicology and Detoxification Masterclass Webinar 4
Module VI: Mitochondrial Restoration and Infections (Friday, February 9, 2018 and Saturday, February 10, 2018)
Module VI: Mitochondrial Restoration and Infections Session Schedule (Sunday, February 11, 2018) - Filomena
Module II - Cardiology A Revolution in the Diagnosis, Prevention and Treatment of Cardiovascular Disease (Fri, Feb 9, 2018 9:00 AM Sun, Feb 11, 2018 4:00 PM)
Dr Filomena- Type 2 Diabetes Mellitus: Pathophysiology, Diagnosis, Prevention and Treatment (Saturday February 10, 2018)
- A Metabolic Approach to Insulin Resistance
- Personalizing BHRT
Integrating Detoxification Science and Personalized Medicine to Improve Oncology Clinical Outcomes- November 9, 2017
The Future of Medicine includes a Functional Approach- November 11, 2017
Metagenics Advanced Practitioner Services (MAPS) is an educational program designed to help practitioners on their journey through lifestyle medicine. Join Metagenics for a VIP dinner followed by an engaging presentation by Filomena Trindade, MD, MPH.
• Understand the symptoms, including vasomotor symptoms (VMS), often reported by women transitioning into the perimenopausal and menopausal stages of life
• Discuss emerging links between VMS and increased risk for cardiovascular (CV) and cardiometabolic (CM) events during the perimenopausal transition stage
• Evaluate current patient management approaches and most recent evidence supporting safety and efficacy of ERr 731®/rhaponticin to alleviate VMS and associated health concerns common to perimenopausal and menopausal women
• Review patient management guide for appropriate management of VMS and other potential clinical concerns often associated with the perimenopausal transition
Estrogen Metabolism: Are We Assessing It Properly?
Are you doing all you can to assess your patient’s individual risk for a hormone-related cancer, such as breast cancer in women and prostate cancer in men?
Estrogen-metabolism assessment should be an essential part of a comprehensive preventive or functional health program, regardless of whether the patient is male or female. Each patient’s individual differences, including genetic as well as environmental factors, can affect potential risk.
Optimizing estrogen metabolism includes supporting both phase 1 and phase 2 detoxification pathways, with particular attention to single nucleotide polymorphisms (SNPs) that may be present.
In addition, xenoestrogens and toxin exposure will affect the metabolism of estrogen. The literature supports using estrogen metabolism assessment and optimization as part of a cancer prevention program.
Are you doing all you can to assess your patient’s individual risk? If not, join us for this informative LiveGDX presentation.
- Discuss the role of estrogen metabolism in the evaluation of hormone-related cancer risk
- Learn what environmental and lifestyle factors may affect estrogen detoxification
- Introduce therapeutic options focusing on improved estrogen metabolism
Click on the link below for more information.
For some clinicians, hormone replacement therapy (HRT) in women and men is still considered the fountain of youth; for others, it has become a dangerous area fraught with considerable risk that is avoided completely. Controversies and disagreements abound regarding how to diagnose and measure hormonal dysfunction; how to address safety concerns in prescribing HRT; the form, application and dosage to use; and when and how to insert lifestyle, diet, nutraceutical and botanical treatments.
The Functional Medicine approach is uniquely capable of responding to the controversy surrounding HRT. The Functional Medicine approach is to look upstream and apply dietary modifications, nutraceutical supplementation, and other lifestyle changes before even considering HRT. In this way, the need for HRT can often be minimized or avoided.
IFM’S HORMONE ADVANCED PRACTICE MODULE
This Functional Medicine Advanced Practice Module will clarify exactly how to approach hormonal dysregulation, with discussions on the most important evaluations to make and integrative treatment approaches to apply. We will help you analyze the controversies and provide you with tools that you can use immediately in your practice.
Our expert faculty team will supply you with the foundational background, insight, and in-depth clinical thinking to confidently assess and treat patients who present with hormonal dysfunction. This program will provide a unique, experiential, case-based, clinically practical experience from which you will acquire the tools you need to apply a comprehensive Functional Medicine approach to hormone dysfunction in your patients.
Dr. Trindade Will be lecturing at CESPU in Famalicao, Portugal at a postgraduate fellowship in Orthomolecular and Functional Medicine. Her focus is Hormones July 7-8, 2017
This webinar will review clinical pearls from A4M’s groundbreaking Lab Interpretation workshop that was created to fill gaps in knowledge, and assist practitioners in providing customized care to patients. Laboratory testing of food reactions, digestion and absorption, nutrient status, genomic SNPs, toxicants, cardiovascular health status, and hormones will all be used to explain how testing can aid clinicians in targeting treatments to individualize and customize a patient’s care.
Testing can help clinicians move beyond the traditional paradigm of treating symptoms by providing the tools to assess patient status and impairments in biochemical pathways to discover the etiology of the disease.
- What are the essential laboratory tests to utilize in patient care.
- How to interpret laboratory results and what are key findings.
- How to individualize and customize a patient’s care based on laboratory results.
CASI conference in San Francisco
Dr Trindade will be one of the invited speakers at the CASI conference in San Francisco on March 17 and 18, 2017.
She will be talking about estrogen metabolism, methylation and beyond - as it applies to cancer prevention.